New Cosponsor — Sep 23, 2010
New Cosponsor: Rep. Mary Jo Kilroy [D-OH15, 2009-2010]
Jun 15, 2009
111th Congress, 2009–2010
This bill was introduced on June 15, 2009, in a previous session of Congress, but was not enacted.
Representative for Massachusetts's 7th congressional district
Read Text »
Last Updated: Jun 15, 2009
Length: 5 pages
Enacted — Signed by the President — Oct 5, 2010
To provide for a disregard under the Supplemental Security Income program of compensation for participation in clinical trials for rare diseases or conditions.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Enacted — Signed by the President
Oct 5, 2010
The “H.R.” in “H.R. 2866” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 2866 — 111th Congress: Improving Access to Clinical Trials Act of 2009. Retrieved from https://www.govtrack.us/congress/bills/111/hr2866
“H.R. 2866 — 111th Congress: Improving Access to Clinical Trials Act of 2009.” www.GovTrack.us. 2009. May 29, 2015 <https://www.govtrack.us/congress/bills/111/hr2866>
|title=H.R. 2866 (111th)
|accessdate=May 29, 2015
|author=111th Congress (2009)
|date=June 15, 2009
|quote=Improving Access to Clinical Trials Act of 2009